US Stock MarketDetailed Quotes

TRVI Trevi Therapeutics

Watchlist

2.840
-0.060-2.07%

Trading Jul 17 15:47 ET

200.04MMarket Cap-8352P/E (TTM)

Trevi Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-27.69%-10.47M

-12.55%-31.71M

-0.44%-6.36M

15.12%-7.28M

-59.89%-9.88M

-15.58%-8.2M

2.66%-28.18M

-1.64%-6.33M

-18.44%-8.58M

21.80%-6.18M

Net income from continuing operations

-70.32%-10.9M

0.30%-29.07M

-42.07%-7.82M

6.87%-7.7M

11.26%-7.15M

12.66%-6.4M

14.11%-29.15M

35.39%-5.51M

-13.94%-8.27M

17.79%-8.05M

Operating gains losses

----

-93.20%10K

--0

-9.09%10K

279.27%147K

--0

440.00%136K

Depreciation and amortization

84.21%35K

186.05%123K

133.33%35K

288.89%35K

325.00%34K

72.73%19K

-14.00%43K

25.00%15K

-30.77%9K

-33.33%8K

Other non cash items

48.15%120K

7.12%557K

11,700.00%118K

-23.23%119K

13.81%239K

-47.40%81K

-46.61%520K

-99.36%1K

2.65%155K

-59.69%210K

Change In working capital

96.58%-62K

-212.51%-3.85M

194.12%736K

124.44%207K

-377.19%-2.98M

-168.20%-1.81M

-181.58%-1.23M

-147.83%-782K

-21.87%-847K

63.22%1.07M

-Change in prepaid assets

169.86%584K

-374.21%-2.85M

486.36%85K

-242.04%-446K

-25.89%-1.65M

-299.05%-836K

-275.73%-601K

-104.74%-22K

-33.19%314K

-3.30%-1.31M

-Change in payables and accrued expense

33.88%-646K

-58.25%-997K

185.66%651K

156.24%653K

-155.47%-1.32M

10.86%-977K

-153.98%-630K

-164.90%-760K

0.34%-1.16M

23.74%2.39M

Cash from discontinued investing activities

Operating cash flow

-27.69%-10.47M

-12.55%-31.71M

-0.44%-6.36M

15.12%-7.28M

-59.89%-9.88M

-15.58%-8.2M

2.66%-28.18M

-1.64%-6.33M

-18.44%-8.58M

21.80%-6.18M

Investing cash flow

Cash flow from continuing investing activities

-190.28%-8.09M

155.35%59.43M

126.59%12.85M

470.76%17.98M

136.22%19.64M

8.96M

-107.37M

-48.31M

-4.85M

-54.22M

Net PPE purchase and sale

--0

13.84%-137K

81.03%-22K

58.14%-18K

---40K

---57K

---159K

---116K

---43K

--0

Net investment purchase and sale

-189.71%-8.09M

155.56%59.57M

126.70%12.87M

474.45%18M

136.30%19.68M

--9.02M

---107.21M

---48.19M

---4.81M

---54.22M

Cash from discontinued investing activities

Investing cash flow

-190.28%-8.09M

155.35%59.43M

126.59%12.85M

470.76%17.98M

136.22%19.64M

--8.96M

---107.37M

---48.31M

---4.85M

---54.22M

Financing cash flow

Cash flow from continuing financing activities

98.36%-28K

-107.11%-7.91M

-108.28%-54K

-97.27%1.51M

-113.69%-7.66M

-172.48%-1.7M

435.77%111.31M

-95.26%652K

41,170.15%55.3M

1,933.35%55.98M

Net issuance payments of debt

98.17%-32K

-62.94%-9.5M

98.17%-32K

98.23%-31K

-339.49%-7.69M

-200.17%-1.75M

---5.83M

---1.75M

Net common stock issuance

----

-98.38%1.71M

--0

-96.66%1.71M

----

397.62%105.41M

-82.45%2.4M

9,503.00%51.18M

----

Proceeds from stock option exercised by employees

-93.55%4K

-98.81%142K

9.09%36K

-99.95%3K

-99.31%41K

3,000.00%62K

28,416.67%11.98M

32.00%33K

--6.03M

34,682.35%5.91M

Net other financing activities

----

-4.45%-258K

-87.10%-58K

-6.83%-172K

-18.18%-13K

65.91%-15K

45.11%-247K

-181.58%-31K

59.65%-161K

81.03%-11K

Cash from discontinued financing activities

Financing cash flow

98.36%-28K

-107.11%-7.91M

-108.28%-54K

-97.27%1.51M

-113.69%-7.66M

-172.48%-1.7M

435.77%111.31M

-95.26%652K

41,170.15%55.3M

1,933.35%55.98M

Net cash flow

Beginning cash position

157.34%32.4M

-65.82%12.59M

-61.00%25.97M

-44.32%13.75M

-59.98%11.65M

-65.82%12.59M

-18.16%36.83M

127.08%66.57M

-32.19%24.7M

-29.97%29.11M

Current changes in cash

-1,881.45%-18.59M

181.71%19.81M

111.91%6.43M

-70.84%12.21M

147.59%2.1M

87.85%-938K

-196.67%-24.24M

-818.65%-53.99M

689.22%41.88M

14.19%-4.42M

End cash Position

18.54%13.81M

157.34%32.4M

-61.00%25.97M

-44.32%13.75M

-59.98%11.65M

-65.82%12.59M

127.08%66.57M

-32.19%24.7M

Free cash flow

-26.81%-10.47M

-12.40%-31.85M

1.02%-6.38M

15.34%-7.3M

-60.54%-9.92M

-16.38%-8.25M

2.11%-28.33M

-3.50%-6.45M

-19.03%-8.62M

21.80%-6.18M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-27.69%-10.47M	-12.55%-31.71M	-0.44%-6.36M	15.12%-7.28M	-59.89%-9.88M	-15.58%-8.2M	2.66%-28.18M	-1.64%-6.33M	-18.44%-8.58M	21.80%-6.18M
Net income from continuing operations	-70.32%-10.9M	0.30%-29.07M	-42.07%-7.82M	6.87%-7.7M	11.26%-7.15M	12.66%-6.4M	14.11%-29.15M	35.39%-5.51M	-13.94%-8.27M	17.79%-8.05M
Operating gains losses	----	-93.20%10K	--0	--0	--0	-9.09%10K	279.27%147K	--0	--0	440.00%136K
Depreciation and amortization	84.21%35K	186.05%123K	133.33%35K	288.89%35K	325.00%34K	72.73%19K	-14.00%43K	25.00%15K	-30.77%9K	-33.33%8K
Other non cash items	48.15%120K	7.12%557K	11,700.00%118K	-23.23%119K	13.81%239K	-47.40%81K	-46.61%520K	-99.36%1K	2.65%155K	-59.69%210K
Change In working capital	96.58%-62K	-212.51%-3.85M	194.12%736K	124.44%207K	-377.19%-2.98M	-168.20%-1.81M	-181.58%-1.23M	-147.83%-782K	-21.87%-847K	63.22%1.07M
-Change in prepaid assets	169.86%584K	-374.21%-2.85M	486.36%85K	-242.04%-446K	-25.89%-1.65M	-299.05%-836K	-275.73%-601K	-104.74%-22K	-33.19%314K	-3.30%-1.31M
-Change in payables and accrued expense	33.88%-646K	-58.25%-997K	185.66%651K	156.24%653K	-155.47%-1.32M	10.86%-977K	-153.98%-630K	-164.90%-760K	0.34%-1.16M	23.74%2.39M
Cash from discontinued investing activities
Operating cash flow	-27.69%-10.47M	-12.55%-31.71M	-0.44%-6.36M	15.12%-7.28M	-59.89%-9.88M	-15.58%-8.2M	2.66%-28.18M	-1.64%-6.33M	-18.44%-8.58M	21.80%-6.18M
Investing cash flow
Cash flow from continuing investing activities	-190.28%-8.09M	155.35%59.43M	126.59%12.85M	470.76%17.98M	136.22%19.64M	8.96M	-107.37M	-48.31M	-4.85M	-54.22M
Net PPE purchase and sale	--0	13.84%-137K	81.03%-22K	58.14%-18K	---40K	---57K	---159K	---116K	---43K	--0
Net investment purchase and sale	-189.71%-8.09M	155.56%59.57M	126.70%12.87M	474.45%18M	136.30%19.68M	--9.02M	---107.21M	---48.19M	---4.81M	---54.22M
Cash from discontinued investing activities
Investing cash flow	-190.28%-8.09M	155.35%59.43M	126.59%12.85M	470.76%17.98M	136.22%19.64M	--8.96M	---107.37M	---48.31M	---4.85M	---54.22M
Financing cash flow
Cash flow from continuing financing activities	98.36%-28K	-107.11%-7.91M	-108.28%-54K	-97.27%1.51M	-113.69%-7.66M	-172.48%-1.7M	435.77%111.31M	-95.26%652K	41,170.15%55.3M	1,933.35%55.98M
Net issuance payments of debt	98.17%-32K	-62.94%-9.5M	98.17%-32K	98.23%-31K	-339.49%-7.69M	-200.17%-1.75M	---5.83M	---1.75M	---1.75M	---1.75M
Net common stock issuance	----	-98.38%1.71M	--0	-96.66%1.71M	----	----	397.62%105.41M	-82.45%2.4M	9,503.00%51.18M	----
Proceeds from stock option exercised by employees	-93.55%4K	-98.81%142K	9.09%36K	-99.95%3K	-99.31%41K	3,000.00%62K	28,416.67%11.98M	32.00%33K	--6.03M	34,682.35%5.91M
Net other financing activities	----	-4.45%-258K	-87.10%-58K	-6.83%-172K	-18.18%-13K	65.91%-15K	45.11%-247K	-181.58%-31K	59.65%-161K	81.03%-11K
Cash from discontinued financing activities
Financing cash flow	98.36%-28K	-107.11%-7.91M	-108.28%-54K	-97.27%1.51M	-113.69%-7.66M	-172.48%-1.7M	435.77%111.31M	-95.26%652K	41,170.15%55.3M	1,933.35%55.98M
Net cash flow
Beginning cash position	157.34%32.4M	-65.82%12.59M	-61.00%25.97M	-44.32%13.75M	-59.98%11.65M	-65.82%12.59M	-18.16%36.83M	127.08%66.57M	-32.19%24.7M	-29.97%29.11M
Current changes in cash	-1,881.45%-18.59M	181.71%19.81M	111.91%6.43M	-70.84%12.21M	147.59%2.1M	87.85%-938K	-196.67%-24.24M	-818.65%-53.99M	689.22%41.88M	14.19%-4.42M
End cash Position	18.54%13.81M	157.34%32.4M	157.34%32.4M	-61.00%25.97M	-44.32%13.75M	-59.98%11.65M	-65.82%12.59M	-65.82%12.59M	127.08%66.57M	-32.19%24.7M
Free cash flow	-26.81%-10.47M	-12.40%-31.85M	1.02%-6.38M	15.34%-7.3M	-60.54%-9.92M	-16.38%-8.25M	2.11%-28.33M	-3.50%-6.45M	-19.03%-8.62M	21.80%-6.18M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion	--	--	--	--	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall